Meeting
2014 ASCO Annual Meeting
Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting.
Authors
Lindsay Carol Overton
Oregon Health & Science University, Portland, OR
Lindsay Carol Overton , Christopher L. Corless , Manish Agrawal , Vasily J. Assikis , Nancy L. Beegle , Sibel Blau , Marc Chernoff , Stephen G. Divers , David H. Henry , Petros Nikolinakos , Colleen Oliver , Eric Scott Schaefer , Frederick M. Schnell , Dennis Slater , Daniel Lewis Spitz , Vicki Tosher , Robert J. Green
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 11028)
DOI
10.1200/jco.2014.32.15_suppl.11028
Abstract #
11028
Poster Bd #
17
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
First Author: Rachna T. Shroff
Poster
2018 ASCO Annual Meeting
Upfront next generation sequencing in NSCLC: A publicly funded perspective.
First Author: Kirstin Perdrizet
Poster
2020 Gastrointestinal Cancers Symposium
Molecular profiling of early-stage colorectal cancer (CRC) using targeted next generation sequencing (NGS) to predict signatures of recurrence.
First Author: Michael C. Burns